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Inducible nitric oxide synthase mRNA and activity in glomerular
mesangial cells. Previous studies have suggested that glomerular mesang-
ial cells produce nitric oxide (NO), using measurements of the NO
decomposition products, NO2- and N03. We have now directly mea-
sured NO in the headspace above rat mesangial cell cultures, using a
chemiluminescence analyzer. In addition, we examined mesangial cell
RNA for inducible NO synthase (iNOS). We found no detectable NO in
the headspace or iNOS mRNA in unstimulated mesangial cells. However,
after four hours of incubation with LPS (10 gIml), iNOS mRNA was
apparent and after six hours, significant increases in NO were detected.
Both of these parameters continued to increase for at least 24 hours.
Significant increases in N02/N03 in the media and cGMP in the
mesangial cells were also detected after 24 hours of incubation with LPS.
The induction of iNOS mRNA by LPS was markedly inhibited by
actinomycin D and dexamethasone, as was the accumulation of NO2/
N03 in the media. Cycloheximide significantly inhibited NO2/N03 in
the media of LPS-treated cells, but had little effect on induction of iNOS
mRNA by LPS. We conclude that rat mesangial cells possess an iNOS,
with activity and regulation similar to that described in macrophages.
Furthermore, we demonstrate the activity of this enzyme by direct
measurement of NO and its decomposition products, NO2 and N03.
We suggest that production of NO by glomerular mesangial cells could
occur, even when macrophage infiltration is not present, and could,
thereby, modulate glomerular and tubular functions within the kidney.
Nitric oxide (NO) was first described as an endothelium-derived
relaxing factor [1], but is now known to have many other biological
actions. NO inhibits platelet aggregation and adhesion [21, mediates
macrophage antimicrobial and antitumoricidal properties [31 and
functions as a local neurotransmitter [4]. Within the kidney, NO
helps to maintain basal vascular tone [5, 6], mediate vasodilatation
secondary to acetylcholine [5] and amino acids [7], and inhibit
contraction and proliferation of glomerular mesangial cells [8,9]. NO
is formed from the terminal guanidino nitrogen of L-arginine by NO
synthase (NOS). This enzyme exists as a constitutive isoform (cNOS)
in vascular endothelium [10] and cerebellum [4], which is calcium-
and calmodulin-dependent. Inducible isoforms (INOS), which are
calcium and calmodulin-independent, have also been described in
endothelial cells [11], as well as in macrophages [12, 13], vascular
smooth muscle cells [14] and hepatocytes [15, 16]. iNOS is induced by
cytokines and endotoxin (lipopolysaccharide, LPS), but only after
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several hours of exposure [13—16]. Once induced, however, NO
production is sustained for prolonged periods by the iNOS.
In a previous study [17] we demonstrated that the stable
decomposition products of NO, nitrate (N03) and nitrite
(NO2), are increased in the culture media of rat mesangial cells
after 24 hours incubation with LPS. The increase in NO2T/N03
was accompanied by an increase in cGMP within the mesangial
cells and both were inhibited by the NO synthesis inhibitor,
N0-monomethyl-L-arginine. However, the capacity of mesangial
cells to produce NO remains in question. Cattel et al [18, 19] have
suggested that glomerular NO production comes from infiltrating
macrophages rather than from intrinsic glomerular cells. In the
present study we have performed direct measurements of NO and
correlated them with NO2 /N03 and cGMP measurements
from the same rat glomerular mesangial cells. In addition, we have
examined mRNA from these cells to determine the isoform of
NOS present and to examine its regulation.
Methods
Mesangial cell culture and incubation
Rat glomerular mesangial cells were cultured as previously
described [8, 17]. Briefly, cells were grown from collagenase-
treated glomerular explants and passed by trypsinization when
confluent. In the present experiments, mesangial cells were used
after the second passage. In previous studies utilizing identical
culture techniques, we have found that <1% of the cells at this
stage of the cultures are positive for Ia or common leukocyte
antigen [17], documenting that there is no significant macrophage
contamination of these cultures.
Actively growing, confluent mesangial cells were washed twice
and incubated with Eagle's MEM without phenol red, which had
been supplemented with 10% fetal calf serum (Hyclone, Logan,
Utah, USA) and 1 mM L-arginine (Sigma Chemical Co., St. Louis,
Missouri, USA) [12, 17]. Incubations included Escherichia coli
LPS (serotype 0127:B8, Difco Laboratories (Detroit, Michigan
USA) at 0.1 to 100 jg/ml, alone or with the NO synthesis
inhibitor, N-nitro-L-arginine methyl ester (L-NAME, Sigma) at
a final concentration of iO M. In other experiments, mesangial
cells were incubated with LPS plus actinomycin D (0,2 j.g/ml),
cyclohexamide (10 M) or dexamethasone (106 all obtained
from Sigma). Control cells were incubated with media and saline
or vehicle in equal volumes. Incubations were conducted for
variable time periods from 2 to 48 hours. All media and solutions
were prepared in endotoxin-free deionized, distilled water which
was periodically checked for endotoxin contamination by limulus
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assay (Associates of Cape Cod, Woods Hole, Massachusetts,
USA) and discarded if levels exceeded 0.01 pglml.
Chemiluminescence assay
This assay was originally developed to measure NO as an
atmospheric pollutant and is based on the observation that ozone
interacts with NO to generate light. The luminescence is detected
by a photomultiplier tube, as previously described [20, 21]. Light
emission (mV) is directly proportional to NO over the range of 20
to 1000 pmole [21]. NO has a high partition coefficient (>20) and
therefore rapidly leaves the liquid phase and accumulates in the
gas phase. Few other substances are both volatile and able to
interact with ozone to emit light. Therefore, the sensitivity and
specificity of this assay are both increased by sampling from the
gas phase in the headspace above the culture media, rather than
the media itself. To detect NO production, mesangial cells in 75
cm2 flasks were equilibrated with 95% air, 5% CO2 and then
incubated with 6 ml of control media, media containing LPS or
media with LPS plus L-NAME. Airtight rubber stoppers with a
sampling port were inserted into the flasks and kept in place with
the port clamped during the incubation. After two hours, the
entire volume of the headspace above the incubation media was
suctioned into the chemiluminescence analyzer (Sievers 270,
Boulder, Colorado, USA) using tubing which had been flushed
with nitrogen. The resulting electrical signal, measured in mV
with an integration time of 0.06 seconds, was converted to pmoles
of NO by comparing the signal of the sample with a calibration
curve derived from NO standards [20]. The flasks were re-
equilibrated with 95% air/5% C02, resealed and the incubations
were continued. After 6 and 24 hours, the sampling was repeated.
NOj7N03
Total N02 plus NO3 was measured simultaneously in the
media of the same mesangial cells in which the chemilumines-
cence measurements of NO were made in the headspace. Incu-
bation conditions and times were identical to those described
above. Aliquots of media (500 gil) were removed from the flask,
centrifuged to remove cell fragments and frozen at —20°C until
assay. On the day of assay, each sample was treated with E. co/i
nitrate reductase as previously described [22], in order to reduce
the N03 in the sample to N02. After reduction, the samples
were incubated with the Griess reagent [17, 22] and total NO2/
N03 (representing N02 and reduced NO3—) was calculated
from a standard curve. This assay can detect N02 in a range of
5 to 500 M.
RNA isolation and iNOS probe
After incubating mesangial cells as described above, total RNA
was isolated using the phenol chloroform method described by
Chomczynski and Sacchi [23]. The RNA was dissolved in sterile
water and RNA concentrations determined by absorbance read-
ings at 260 nm. Total RNA (5 to 15 j.g per lane) was separated by
electrophoresis in a 1% agarose gel containing 20 mM MOPS, 1
mM EDTA, 5 mivi sodium acetate (pH 7.0) and 2.2 M formalde-
hyde. An RNA ladder (BRL, Gaithersburg, Maryland, USA) was
run in some gels to size the hybridized mRNA. Ethidium bromide
was added to each lane to allow visualization of the RNA with UV
light. After electrophoresis, the RNA was transferred to nylon
membranes (Duralon UVTM Stratagene, La Jolla, California,
USA) and fixed by ultraviolet crosslinking (Stratalinker, Strat-
agene, California, USA). Membranes were prehybridized at 60°C
for four hours in a buffer containing 5 X SSC, 5 X Denhardt's
reagent, 50 mi Tris-hydrochioride, pH 7.5, 0.1% sodium pyro-
phospate, 0.2% SDS, 200 j.g/ml sonicated, denatured salmon
testes DNA, and 100 g/ml yeast tRNA. The membranes were
then hybridized at 42°C with 32P-labeled iNOS cDNA probe (see
below) for 16 to 18 hours in a buffer containing 50% deionized
formamide, 5x SSC, lx Denhardt's reagent, 50 mrs Tris-hydro-
chloride, pH 7.5, 0.1% sodium pyrophospate, 1% SDS, 100 g/ml
salmon testes DNA, and 100 Wml yeast tRNA. Two washes in
2x SSC and 0.1% SDS for 45 minutes were performed at room
temperature and one at 60°C, followed by a wash in 0.2x SSC and
0.1% SDS at 60°C for 45 minutes. Autoradiographs and the
ethidium bromide stained blots were photographed under UV
light (Kodak XAR-5 film) and the 28s and 18s ribosomal RNA
was quantified from the negative using computer-assisted video-
densitometry. This techniques verifies the absence of degradation
and the presence of equivalent loading and transfer of the RNA
to the membrane. In addition, the iNOS mRNA signal on the
autoradiograph can be corrected for the 28s RNA on the mem-
brane for each lane, so that changes in iNOS mRNA signal are
corrected for any variability in loading or transfer of the RNA
[24].
The eDNA probe for iNOS used in these studies was cloned
from mouse macrophages and kindly provided by Drs. Carl
Nathan and Qiao-wen Xie (Cornell University Medical College)
[13]. The probe was labeled with 32P-dCTP (6000 Cilmmol; NEN
Dupont, Wilmington, Delaware, USA), using the random oligo-
nucleotide-primer method (Promega, Madison, Wisconsin, USA).
Only probes with a specific activity> 1 X iO cpm/g DNA were
used for hybridization.
cGMP measurements
In three experiments, passage 2 rat mesangial cells grown in
flasks were incubated in triplicate with normal saline, LPS (10
.g/ml) or LPS + L-NAME (i0— M). At the end of 24 hours, NO
and NO2INO3 were measured as described above, and intracellu-
lar cGMP was measured in the cells. cGMP was extracted by
adding ice-cold 0.1 N HCI to the cells for one hour and measured
by RIA after acetylation of the samples, as previously described
[17].
Results
Rat mesangial cells incubated with LPS (10 pgIml) showed
significant increases in NO in the headspace above the media after
6 and 24 hours, compared to cells incubated with control media
(Fig. 1). NO was not detectable in the headspace after only two
hours incubation with LPS. When cells were incubated with LPS
plus the NO synthesis inhibitor, L-NAME (10—s M), NO produc-
tion at 24 hours was completely inhibited (P < 0.05 vs. LPS-
treated cells). The concentration of N021N03 in the media of
the same mesangial cells was measured simultaneously and is
shown in Figure 2. No significant differences in N02/NO3
concentrations were detectable in LPS-treated cells, compared to
control cells, after two to six hours of incubation. However, as we
have previously reported [17], significant accumulation of NO2/
NO3 was found in mesangial cell culture media after 24 hours of
incubation with LPS (P < 0.05 vs. control cells). The LPS-induced
increase in NO2/N03 was markedly inhibited by L-NAME
(Fig. 2).
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Fig. 1. Amount of NO detected in the headspace above rat mesangial cell
cultures after the incubation times shown. NO was detected using a chemilu-
minescence analyzer and quantitated by comparing the electrical signal to a
calibration curve of known NO concentrations. Control cells (•) were
incubated with MEM media containing 10% serum and 1 mM L-arginine.
LPS-treated cells (0) were incubated with the same media plus E. co/i
lipopolysaccharide (10 rgIml). LPS + L-NAME cells (A) were incubated
with LPS plus N-nitro-L-arginine methyl ester (10- M). Cells treated with
LPS + L-NAME were analyzed after 24 hours only. Mean SE, N = 9 to 11
flasks for each determination. *p < 0.05 vs. control; P < 0.05 vs. LPS.
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Fig. 2. Amount of NO27NO3 in the media of rat mesangial cells after the
incubation times shown. Total N02/N03 was determined using the
Griess reagent after reduction of the samples. Control cells (S) were
incubated with MEM media containing 10% serum and 1 mM L-arginine.
LPS-treated cells (0) were incubated with the same media plus E. co/i
lipopolysaccharide (10 jrg/ml). LPS + L-NAME cells (A) were incubated
with LPS plus N-nitro-L-arginine methyl ester (1O M). Cells treated with
LPS + L-NAME were analyzed after 24 hours only. Mean SE, N = 9 to 11
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In some experiments, we simultaneously measured NO in the
headspace, N02/N03 in the media and intracellular levels of
the secondary messenger, cGMP, in the same mesangial cell
flasks. As shown in Figure 3, along with NO and N02/N03,
cGMP was also markedly increased after 24 hours incubation with
LPS (10 tg/ml) (P < 0.05 vs. control for each measurement, N =
3 separate experiments). The increase in NO, N02/N03 and
cGMP in response to LPS was markedly inhibited by L-NAME
(10 Fig. 3).
Figure 4 shows a representative experiment examining mesang-
ial cell RNA for iNOS mRNA. Figure 4A is an autoradiogram of
a Northern blot, hybridized with the mouse macrophage eDNA
probe for iNOS [13]. Total RNA was prepared from mesangial
cells incubated with LPS (10 g/ml) for five minutes, and 4, 24 and
48 hours. iNOS mRNA could not be detected after five minutes of
LPS incubation. In control cells, not exposed to LPS, we also have
been unable to detect iNOS mRNA using these techniques (data
not shown). However, iNOS mRNA was apparent after four hours
of exposure to LPS and by 24 hours there was a marked induction
of this mRNA in mesangial cells (Fig. 4A). The signal for iNOS
mRNA was increased even further after 48 hours of LPS incuba-
tion. The iNOS mRNA we detected in rat mesangial cells was
approximately 4.4 kb (Fig. 4A), which is similar to the size of the
iNOS mRNA described in other cells [13—16]. The N027N03
levels in the media at the time the RNA was obtained is shown at
the bottom of each lane in Figure 4A, and confirms that induction
of iNOS mRNA by LPS is associated with an increase in the
amount of these decomposition products at 24 and 48 hours.
Figure 4B, shows a photograph of the ethidium bromide stained
membrane used for the Northern hybridization in 4A. The 28s and
18s ribosomal RNA signals are clearly visible and of similar
intensity in each lane. Figure 4C depicts the densitometry of the
signal for iNOS mRNA from the autoradiograph corrected for
the signal from the 28s RNA on the blot and confirms that the
changes in the level of iNOS mRNA with time are not due to
differences in RNA loading or transfer. As can be seen by this
graph, the corrected iNOS signal increased by at least 8-fold after
24 hours of incubation with LPS. Similar levels of induction of
iNOS mRNA was seen with concentrations of LPS ranging from
0.1 to 100 .tg/ml (data not shown). No morphologic evidence of





Fig. 3. Comparison of NO in the headspace measured by chemilumines-
cence (A), NO2 !NO3 in the media measured by the Greiss Reagent (B) and
intracellular cGMP measured by RIA (C) from the same rat mesangial cell
cultures. Cells were incubated with MEM media containing 10% serum
and 1 mai L-arginine only (control), LPS (10 g/m1) or LPS + L-NAME
(10 M) for 24 hours in 75 cm2 flasks. Data are the mean SEM of 3
experiments, with each condition in duplicate flasks. * P < 0.05 vs. control.
cell toxicity was detected with these concentrations of LPS.
Furthermore, in previous studies [17], we found no increased
LDH release or reduction in mesangial cell number after incuba-
tions with LPS under similar conditions and concentrations.
Figure 5A and B show a representative autoradiograph and
ethidium bromide stained membrane from an experiment exam-
ining the regulation of LPS-induced INOS mRNA induction.
Shown in lane 1 is RNA prepared from mesangial cells incubated
with LPS (10 gIml) for 24 hours. Lane 2 is RNA from cells
incubated with LPS plus the RNA synthesis inhibitor, actinomycin
D (0.2 gfml). As expected, actinomycin D markedly inhibited the
induction of iNOS mRNA in these cells. Lane 3 in Figure 5A and
B shows RNA from cells incubated with LPS and cycloheximide
(10 M), which had little effect on the amount of iNOS mRNA
induced by LPS. In experiments not shown, cycloheximide was
noted to have a variable effect on iNOS mRNA induced by LPS.
In one experiment, cycloheximide appeared to partially inhibit
induction of this mRNA, while in another there appeared to be a
stimulatory effect. In four other experiments, including the North-
ern shown in Figure 5A, cycloheximide had no effect on induction
of iNOS mRNA in mesangial cells. Lane 4 in Figure 5 is RNA
prepared from mesangial cells incubated with LPS plus dexameth-
asone (106 M) for 24 hours, As can be seen, dexamethasone
markedly inhibited the induction of iNOS mRNA by LPS. Figure
SB confirms that the RNA loading and transfer was similar in all
lanes of the membrane.
The effect of actinomycin D, cycloheximide and dexamethasone
on LPS-stimulated increases in N02/N03 in the media of
mesangial cells after 24 hours incubation is shown in Figure 6. The
data shown are the mean SE of four to six experiments,
including the experiment shown in Figure 5. Consistent with their
effect of inhibiting induction of the iNOS mRNA, actinomycin D
and dexamethasone both significantly inhibited the increase in
NO2/NO3 seen with LPS. Cycloheximide also consistently and
significantly inhibited LPS-induced NO27NO3 production by
mesangial cells, despite the fact that it had little inhibitosy effect
on induction of INOS mRNA. This would suggest that protein
synthesis is not required for transcription of iNOS mRNA, but is
required for translation of mRNA into active enzyme.
Discussion
Messenger RNA for iNOS has recently been cloned from rat
macrophages [281, vascular smooth muscle cells [14], and from rat
and human hepatocytes [15, 16]. All iNOS thus far identified have
high degrees of homology, resulting in deduced amino acid
sequences which are very similar to each other. In contrast, iNOS
is quite distinct from the cNOS which have been cloned thus far,
showing an amino acid identity of only about 50% [4, 13]. Several
investigators have begun to localize NOS in the kidney. Mundel et
a! [29] have demonstrated cNOS in the macular densa using in situ
hybridization with a probe from rat brain. Using polymerase chain
reaction (PCR) and reverse transcription, Terada et a! [30] found
cNOS in the inner medullary collecting ducts, glomeruli, and
outer medullary collecting ducts of microdissected nephrons. A
recent study of cultured proximal tubule and inner medullary
collecting duct cells in culture has demonstrated N02 produc-
tion by these cells after 72 hours incubation with y-interferon and
tumor necrosis factor [31]. Messenger RNA for iNOS was also
found in these cells, but only with PCR, suggesting it is in low
abundance. No reports of iNOS mRNA in glomerular cells have
been reported at the time of this writing.
In our previous study, incubation of rat mesangial cells with
LPS for 24 hours resulted in significant increases in N021N03
in the media, compared to control cells [171. The increases in
N02/N03 - were accompanied by increases in intracellular
cGMP and both were inhibited by NO synthesis inhibitors,
providing strong circumstantial evidence for NO synthesis. The
present studies confirm and extend our knowledge regarding
mesangial cell NO production. Utilizing the chemiluminescence
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Fig. 5. A. Autoradiograph of a representative Northern blot of rat mesangial
cell RNA, hybridized with radiolabeled probe for iNOS. Lane 1 is RNA from
cells incubated with LPS (10 rgimI) only. Lane 2 is RNA from cells
incubated with LPS plus actinomycin D (0.2 jtg/ml). Lane 3 is RNA from
cells incubated with LPS plus cycloheximide (10—i M) and lane 4 is LPS
plus dexamethasone (106 M). Ten micrograms total RNA was added to
each lane. B. Photograph of the ethidium bromide stained membrane used
for the Northern hybridization in A, demonstrating equivalent RNA
loading and transfer in each lane.
analyzer, we now demonstrate accumulation of NO within the
headspace above the culture media of rat mesangial cells after as
little as six hours incubation with LPS. The time dependent nature
of the NO production is consistent with an inducible isoform of
NOS. Furthermore, increases in mesangial cell NO were accom-
panied by increases in the NO metabolites, N02/N03, and the
second messenger of NO, cGMP. Inhibition of these parameters
crEL(D'O.
Fig. 6. NO2 /N03 — in the media of mesangial cells, shown as the percent of
the LPS-stimulated response in the same experiments. Media was analyzed
after 24 hours incubation with LPS (10 .tg/ml) alone, LPS plus actinomy-
cm D (0.2 jtg/ml), LPS plus cycloheximide (10 M) or LPS plus
dexamethasone (106 M). Data are mean 5E, N = 4 to 6 experiments,
with triplicate flasks in each. * P < 0.01 vs. LPS alone.
5mm 4hr 24hr 48hr
Time
Fig. 4. A. Autoradiograph of a representative Northern blot of rat mesangial cell RNA, hybridized with radiolabeled probe for iNOS. Cells were incubated
with LPS (10 xgiml) for the times shown above each lane, prior to extraction of RNA. Five micrograms total RNA was added per lane. Underneath
each lane is the amount of N021N01 detected in the media from these cells at the time of RNA extraction. B. Photograph of the ethidium bromide
stained membrane used for the Northern hybridization in A. The first 4 lanes correspond to the lanes shown in A. The lane on the far right is an RNA
ladder which correlates with the size markers shown in A. C. Graph of the densitometry units from each lane of the autoradiograph shown in A,
corrected for densitometry units from the RNA from the same lane, as shown in B. This corrects the iNOS signal for any differences in loading or











by L-NAME confirms that the NO in the headspace is derived
from L-arginine, and that the increase in N027NO3 in the
media and cGMP within the cells are both dependent on the
production of NO.
Northern hybridization with a probe cloned from mouse mac-
rophages, demonstrates the presence of iNOS mRNA in rat
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The induction of iNOS mRNA in mesangial cells resulted in
increases in N02/N03 in the media and NO in the headspace,
as well. We have now examined RNA from more than 12 different
mesangial cell cultures, using the techniques described in this
paper, and can detect no iNOS mRNA in control or unstimulated
cells (that is, cells not exposed to LPS or other cytokines;
unpublished observations). Neither can we detect NO or NO2J
NO3 production above background in unstimulated cells. We,
therefore, conclude that there is little biologically active iNOS
present in mesangial cells in culture in the basal state.
The induction of iNOS mRNA by LPS was prevented by
actinomycin D. Thus, we conclude that new RNA synthesis is
required for induction of this mRNA. Cycloheximide clearly
inhibits LPS-induced increases in NO27NOç in mesangial cells,
but overall had no inhibitory effect on LPS-induced iNOS mRNA.
Thus, we conclude that cycloheximide inhibits the 1-arginine-NO
pathway at the point of translation of the mRNA or beyond. This
is in contrast to the report of Geller et al [16}, in which they
observed an inhibition of iNOS mRNA induction in human
hepatocytes with cycloheximide. The reasons for this difference is
not clear; however, it is possible that iNOS isoforms from different
cell types or species may have different requirements for their
induction.
Several studies have shown that glucocorticoids inhibit endo-
toxin-induced vasodilatation of aortic rings and N02 production
by macrophages [1, 25]. We also find that dexamethasone inhibits
NO production in mesangial cells, since LPS-induced N02/
NO3 production is markedly inhibited in the presence of dexa-
methasone. Furthermore, we find that dexamethasone inhibits the
induction of iNOS mRNA by LPS, and thus conclude that this is
the mechanism for the inhibitory effect of this glucocorticoid.
The minimal concentration of LPS required to detect changes
in NO2JN03 in mesangial cell media after 24 hours was 10
gg/ml [17]. In the present studies, we found changes in NO levels
in the headspace above mesangial cell cultures with LPS concen-
trations of 1 g/ml for as little as six hours, while induction of
iNOS mRNA was detectable by four hours with LPS concentra-
tions 10-fold lower (not shown). We believe these differences are
due to the sensitivities of the different methods employed and/or
the delay in translation from mRNA to protein and from produc-
tion of NO to decomposition. However, it is also possible that the
differences in our ability to detect changes in these parameters
represents a true biological phenomenon in which a small amount
of LPS initiates induction of mRNA, but larger amounts are
required for translation of this message and production of NO. In
addition, LPS may also alter the metabolism of NO [26], which
would affect the amount of NO27NOç produced for any given
concentration of LPS. For these reasons, changes in induction of
iNOS mRNA, translation of the RNA, activity of the NOS
enzyme, as well as decomposition and metabolism of the NO
produced, must all be considered when examining the regulation
of the L-arginine-NO pathway.
We have previously demonstrated increased urinary excretion
of NO27N03 by rats injected with LPS and provided evidence
that renal production contributed significantly to these increases
[22]. Our present findings that glomerular mesangial cells in
culture possess the ability to produce NO via an LPS-stimulated
iNOS is further evidence that the kidney is an important producer
of NO. In addition to LPS, cytokines such as y-interferon [17],
interleukin-1 [17] and tumor necrosis factor [27] have also been
found to induce increases in NO2JNO3 (and presumably NO)
in mesangial cells.
The biological effects of NO in the glomerulus are not ad-
dressed in this study, but have been reviewed elsewhere [9, 32].
The fact that mesangial cell NO production in this study was
accompanied by increases in cGMP, confirms that the NO is
biologically active. In fact, changes in mesangial cell cGMP have
been utilized as a bioassay of NO activity by other investigators
[11j. NO is important in maintaining GFR under basal conditions
and during pathological states when angiotensin II is increased
[33]. Furthermore, NO can inhibit mesangial cell proliferation
and thus could modulate the effects of cytokines and growth
factors in glomerulonephritis [34]. Recent evidence suggests that
endogenous NO may mediate natriuresis, suggesting an action of
NO on the tubules as well [35]. Thus, NO produced by glomerular
mesangial cells could have a number of important actions within
the glomerulus and, perhaps by entering the glomerular filtrate,
could affect tubular function as well.
In summary, we have shown the presence of an inducible NOS
mRNA in rat glomerular mesangial cells in culture, which is
stimulated by LPS, We have confirmed the activity of this enzyme,
by demonstrating increases in NO in the headspace and NO2/
NO in the media of these cells, which follow the induction of
iNOS mRNA. Mesangial NO production could thereby mediate
glomerular function, even when macrophage infiltration is not
present. By simultaneously measuring changes in these different
parameters, we have the ability to explore the regulation of the
L-arginine-NO pathway at a number of different points. This
should lead to a better understanding of the role of mesangial-
derived NO as a mediator of renal function in physiologic and
pathophysiologic situations.
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